Fig. 5: Comparison of the paired IPRP risk score and the other risk scores in AML patient cohorts.
From: An immunity and pyroptosis gene-pair signature predicts overall survival in acute myeloid leukemia
The bars indicate average ROC-AUC and SD over the 1, 2, and 3-year time points. The statistical significance was calculated using paired Wilcoxon test. Red and blue * indicate that the signature had either a lower or higher average ROC-AUC (p < 0.05, Wilcoxon test), compared to IPRP risk score, respectively. # Indicates that the signature was originally developed in that particular patient cohort.
